Regulatory Issues
Company gives FDA ephedra complaints
Published in Medical Letter on the CDC and FDA, December 29th, 2002
Metabolife International already had turned over 14,700 customer health complaints as the Justice Department began a criminal investigation into whether the company had lied about ephedra's safety.
Ephedra is a popular herb commonly used for weight loss and body building, but it also has been linked to heart attacks, strokes and other serious side effects. Critics have called on the Food and Drug Administration to ban sales, and the agency has long sought manufacturers' records of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Obesity Epidemiology
Prevalence of class 3 obesity in the United States climbs - Public Health
Majority of U.S. adults have some health problems - Group B Streptococci
ACOG advises screening all pregnant women - Laboratory Techniques
TaqMan real-time PCR assay is sensitive, reliable for quantitating HCV RNA - Occupational Health Risks
Tumor necrosis factor plays multiple roles in toluene diisocyanate asthma - Anemia
Suit seeks relief from reimbursement ruling - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
